CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Clinical trials for CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE trials appear
Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New two-step transplant method aims to cut deaths in blood cancer patients
Disease control Recruiting nowThis study tests a two-step approach using lower doses of radiation and chemotherapy before a stem cell transplant for people with various blood cancers. The goal is to see if this gentler preparation reduces the risk of death from the treatment itself. About 63 participants will…
Matched conditions: CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 17, 2026 12:05 UTC
-
New cord blood transplant method aims to beat high-risk blood cancers
Disease control Recruiting nowThis study tests a special cord blood transplant for people with high-risk blood cancers like leukemia and lymphoma. Participants get chemotherapy and radiation before the transplant to kill cancer cells and prepare the body. After the transplant, drugs are given to prevent the n…
Matched conditions: CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 17, 2026 12:02 UTC
-
Supercharged immune cells take on returning leukemia in new trial
Disease control Recruiting nowThis early-stage trial tests a new treatment for children and adults (ages 0-80) whose leukemia has come back or not responded after a donor stem cell transplant. The treatment involves taking donor immune cells, adding a special receptor so they can recognize and attack leukemia…
Matched conditions: CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
New stem cell transplant trial offers hope for blood cancer patients
Disease control Recruiting nowThis study tests a stem cell transplant from half-matched (haploidentical) donors for people with various blood cancers. Before the transplant, patients receive chemotherapy and low-dose radiation to prepare their body. The goal is to replace diseased bone marrow with healthy don…
Matched conditions: CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Donor vaccine aims to shield transplant patients from dangerous virus
Prevention Recruiting nowThis study tests whether giving a CMV vaccine to stem cell donors can protect transplant recipients from CMV infection. Donors receive the vaccine before donating stem cells, passing immunity to the patient. The trial involves 216 people with blood cancers and aims to reduce CMV-…
Matched conditions: CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Jun 10, 2026 13:27 UTC
-
Leukemia drugs may fog your brain – study investigates
Knowledge-focused Recruiting nowThis study looks at whether targeted therapy (TKI) for chronic leukemia affects thinking, memory, and well-being. Researchers will compare 400 patients who receive TKI therapy with those who do not. The goal is to understand how these drugs impact brain health over time.
Matched conditions: CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Sponsor: University of Rochester NCORP Research Base • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:49 UTC